Direct-to-consumer (DTC) genetic testing
TG
Genotyping was conducted by the TheragenEtex Bio Institute (TheragenEtex Inc., Suwon, Korea), on peripheral blood collected from subjects at the Seoul National University Health Service Center at the baseline visit. The DTC test report included information on the integrated risk represented as “Good” for not having genotype at risk, “Borderline risk” for carrying one genotype at risk, and “Caution” for having two genotypes at risk regarding each gene item, that is, BMI, TG concentrations, and low-density (LDL) and high-density lipoprotein (HDL) cholesterol levels, as well as recommendations for those at risk (